AKTX Chart
See on advanced chart >
About
Akari Therapeutics, Plc is a biopharmaceutical company dedicated to the discovery and development of novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs. Celsus believe that it has created a new class of synthetic drugs that it term...
Read More
- HighlightA biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases
- ExchangeNASDAQ
- Listing Date01/31/2014
- Established Date10/07/2004
- Full-time Employees12
- Address75/76 Wimpole Street London W1G 9RT United Kingdom
- Tel44-20-80040270
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Pharmaceuticals